|
FDA permits marketing of first medical device for treatment of ADHD
|
23 April 2019 |
|
FDA approves first generic naloxone nasal spray to treat opioid overdose
|
19 April 2019 |
|
FDA approves first targeted therapy for metastatic bladder cancer
|
15 April 2019 |
|
FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture
|
10 April 2019 |
|
FDA expands approved use of metastatic breast cancer treatment to include male patients
|
04 April 2019 |
|
FDA approves treatment for patients with a type of inflammatory arthritis
|
28 March 2019 |
|
FDA approves a new generic valsartan
|
12 March 2019 |
|
FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic
|
06 March 2019 |
|
FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain
|
14 February 2019 |
|
FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease
|
11 February 2019 |
|
FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder
|
06 February 2019 |
|
FDA approves first generic Advair Diskus
|
31 January 2019 |
|
FDA approves first treatment for rare blood disease
|
21 December 2018 |
|
FDA clears mobile medical app to help those with opioid use disorder stay in recovery programs
|
10 December 2018 |
|
FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
|
30 November 2018 |
|
FDA approves new treatment for patients with acute myeloid leukemia
|
22 November 2018 |
|
FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
|
19 November 2018 |
|
FDA highlights record-breaking number of generic drug approvals in October
|
09 November 2018 |
|
FDA approves new drug to treat influenza
|
26 October 2018 |
|
FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs
|
23 October 2018 |